StonvexLoading…
StonvexStonvexStonvexCore line items from LYV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.79B | $25.20B | $18.89B | $10.39B |
Operating Income | $-370.52M | $1.25B | $1.39B | $601.42M |
Net Income | $-389.10M | $495.97M | $698.07M | $266.61M |
EPS (Diluted) | $-1.85 | $-0.24 | $0.82 | $0.09 |
Total Assets | $26.07B | $22.91B | $22.89B | $23.15B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.08B | $7.09B | $6.75B | $7.06B |
Free Cash Flow OCF − CapEx | $2.03B | $333.61M | $739.25M | $1.11B |
Shares Outstanding | 232.40M | 235.42M | 234.73M | 234.66M |